Shoulder disease
Conditions
Interventions
Experimental group 1:Dexamethasone 2 ml (10 mg) was injected intravenously, and ropivacaine 100 mg, dexmedetomidine 50 µg and magnesium sulfate 250 mg were given for supraclavicular brachial plexus bl
Experimental group 2:2 ml of normal saline was injected intravenously, and 100 mg of ropivacaine, 50 µg of dexmedetomidine and 250 mg of magnesium sulfate were given in the supraclavicular brachial pl
Experimental group 3:2 ml of normal saline was injected intravenously, and 100 mg of ropivacaine and 250 mg of magnesium sulfate were given in the supraclavicular brachial plexus block.
Experimental group 4:2 ml of normal saline was injected intravenously, and 100 mg of ropivacaine and 50 µg of dexmedetomidine were given in the supraclavicular brachial plexus block.
Sponsors
The Second Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age between 18-65 years; 2. BMI 18-26; 3. ASA level 1-3; 4. Patients to undergo unilateral shoulder arthroscopy; 5. Agreed to accept the study and willing to complete the follow-up process.
Exclusion criteria
Exclusion criteria: 1. Allergic to related narcotic drugs; 2. Contraindications to brachial plexus block, such as coagulation dysfunction and local infection; 3. Patients with chronic pain and long-term use of analgesics before operation; 4. Patients with cognitive impairment who could not cooperate with postoperative pain assessment; 5. Pregnant and diabetes patients; 6. Liver and kidney dysfunction; 7. Reject participants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time of first request for analgesia;Cumulative opioid consumption; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative VAS score;Nausea and vomiting in patients within 24 hours after surgery;Patient satisfaction on the second postoperative day;Motor block duration;Duration of sensory block;Postoperative neurological complications (persistent numbness, paresthesia, and weakness);Shoulder joint American Shoulder and Elbow Surgeons Society score (ASES score) at discharge;Outcome length of stay; | — |
Countries
China
Contacts
Public ContactMao Nie
The Second Affiliated Hospital of Chongqing Medical University
Outcome results
None listed